Biomea Fusion IncNASDAQ:BMEA
- LAST PRICE4.3500
- TODAY'S CHANGE (%)-0.0800 (-1.8059%)
- Bid / Lots4.3500/ 1
- Ask / Lots4.3700/ 193
- Open / Previous Close4.4400 / 4.4300
- Day Range
- 52 Week Range
- Volume401,838
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMEA |
|---|---|---|
| 09:32 ET | 14838 | 4.368 |
| 09:34 ET | 4920 | 4.36 |
| 09:36 ET | 300 | 4.36 |
| 09:38 ET | 1225 | 4.34 |
| 09:39 ET | 2900 | 4.36 |
| 09:41 ET | 965 | 4.3729 |
| 09:43 ET | 2688 | 4.35 |
| 09:45 ET | 1400 | 4.34 |
| 09:48 ET | 2100 | 4.335 |
| 09:50 ET | 859 | 4.33 |
| 09:52 ET | 3199 | 4.37 |
| 09:54 ET | 802 | 4.375 |
| 09:56 ET | 1175 | 4.37 |
| 09:57 ET | 903 | 4.36 |
| 09:59 ET | 4177 | 4.38 |
| 10:01 ET | 2295 | 4.4544 |
| 10:03 ET | 422 | 4.4401 |
| 10:06 ET | 1467 | 4.44 |
| 10:08 ET | 550 | 4.4399 |
| 10:10 ET | 3340 | 4.46 |
| 10:12 ET | 500 | 4.48 |
| 10:14 ET | 350 | 4.485 |
| 10:15 ET | 563 | 4.5154 |
| 10:17 ET | 1000 | 4.52 |
| 10:19 ET | 1540 | 4.5497 |
| 10:21 ET | 4664 | 4.52 |
| 10:24 ET | 100 | 4.52 |
| 10:26 ET | 100 | 4.51 |
| 10:28 ET | 8469 | 4.495 |
| 10:30 ET | 2003 | 4.5 |
| 10:32 ET | 1844 | 4.485 |
| 10:33 ET | 1050 | 4.47 |
| 10:35 ET | 1213 | 4.45 |
| 10:37 ET | 100 | 4.45 |
| 10:39 ET | 4103 | 4.47 |
| 10:42 ET | 200 | 4.49 |
| 10:44 ET | 1420 | 4.48 |
| 10:46 ET | 1207 | 4.4615 |
| 10:48 ET | 11486 | 4.44 |
| 10:50 ET | 1371 | 4.425 |
| 10:51 ET | 800 | 4.43 |
| 10:53 ET | 1025 | 4.42 |
| 10:55 ET | 1113 | 4.4095 |
| 10:57 ET | 2875 | 4.39 |
| 11:00 ET | 600 | 4.38 |
| 11:02 ET | 4869 | 4.38 |
| 11:04 ET | 359 | 4.385 |
| 11:06 ET | 712 | 4.38 |
| 11:08 ET | 2237 | 4.375 |
| 11:09 ET | 5566 | 4.42 |
| 11:13 ET | 3408 | 4.42 |
| 11:15 ET | 2131 | 4.42 |
| 11:20 ET | 2253 | 4.4 |
| 11:22 ET | 2824 | 4.4 |
| 11:24 ET | 1210 | 4.4077 |
| 11:27 ET | 4593 | 4.41 |
| 11:31 ET | 1955 | 4.4194 |
| 11:33 ET | 895 | 4.41 |
| 11:36 ET | 7582 | 4.39 |
| 11:38 ET | 3700 | 4.37 |
| 11:40 ET | 450 | 4.36 |
| 11:42 ET | 1051 | 4.36 |
| 11:44 ET | 3375 | 4.355 |
| 11:45 ET | 5730 | 4.35 |
| 11:47 ET | 2100 | 4.35 |
| 11:49 ET | 500 | 4.365 |
| 11:51 ET | 4596 | 4.36 |
| 11:54 ET | 200 | 4.3589 |
| 11:56 ET | 2606 | 4.34 |
| 11:58 ET | 100 | 4.34 |
| 12:00 ET | 565 | 4.33 |
| 12:02 ET | 13454 | 4.32 |
| 12:03 ET | 1279 | 4.32 |
| 12:05 ET | 4276 | 4.35 |
| 12:07 ET | 1053 | 4.35 |
| 12:09 ET | 1400 | 4.345 |
| 12:12 ET | 200 | 4.345 |
| 12:14 ET | 300 | 4.345 |
| 12:16 ET | 1892 | 4.34 |
| 12:20 ET | 1647 | 4.335 |
| 12:21 ET | 7862 | 4.31 |
| 12:23 ET | 1300 | 4.3 |
| 12:25 ET | 300 | 4.305 |
| 12:27 ET | 3008 | 4.32 |
| 12:30 ET | 2939 | 4.3179 |
| 12:32 ET | 2999 | 4.31 |
| 12:34 ET | 100 | 4.315 |
| 12:36 ET | 1000 | 4.315 |
| 12:38 ET | 1300 | 4.3136 |
| 12:39 ET | 9426 | 4.32 |
| 12:41 ET | 23593 | 4.345 |
| 12:43 ET | 25729 | 4.34 |
| 12:45 ET | 5093 | 4.35 |
| 12:48 ET | 7782 | 4.32 |
| 12:50 ET | 600 | 4.33 |
| 12:52 ET | 1400 | 4.3292 |
| 12:54 ET | 1800 | 4.325 |
| 12:56 ET | 3176 | 4.34 |
| 12:57 ET | 10358 | 4.34 |
| 12:59 ET | 45120 | 4.35 |
Today
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Biomea Fusion, Inc. Investors to Inquire About Securities Class Action Investigation -- BMEA, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesShareholders With Losses Are Encouraged By The Schall Law Firm To Reach Out As They Begin An Investigation Into Allegations Against Biomea Fusion Inc, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
Yesterday
The Schall Law Firm Is Initiating An Investigation Into Claims Against Biomea Fusion Inc And Encourages Shareholders With Losses To Reach Out, from 1:34PM ET on Tuesday Jul 02, 2024 by Dow Jones
1:34PM ET on Tuesday Jul 02, 2024 by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biomea Fusion, Inc. - BMEA, from 11:15AM ET on Tuesday Jul 02, 2024 by Dow Jones
11:15AM ET on Tuesday Jul 02, 2024 by Dow Jones
Jul 1, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomea Fusion Inc | 159.2M | -1.2x | --- |
INmune Bio Inc | 159.6M | -4.2x | --- |
Achieve Life Sciences Inc | 157.6M | -3.5x | --- |
Elevation Oncology Inc | 153.0M | -2.6x | --- |
Outlook Therapeutics Inc | 165.9M | -0.6x | --- |
Ventyx Biosciences Inc | 150.9M | -0.7x | --- |
Company Information
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Contact Information
- Headquarters
- 900 Middlefield Road, 4Th FloorREDWOOD CITY, CA, United States 94063
- Phone
- 650-980-9099
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Thomas Butler
- President, Co-Founder, Chief Operating Officer, Director
- Rainer Erdtmann
- Chief Financial Officer
- Franco Valle
- Chief Medical Officer
- Juan Fras
- Independent Director
- Eric Aguiar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $159.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
